companydata.dkcompanydata.dk

STRAGEN NORDIC A/S: Financial statements 2024

CVR: 26717825

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 8,494,392 and a net result of DKK 2,665,035 compared with DKK -462,986 the year before. That is an increase of 43.2% compared with the year before. Equity in the 2024 report amounted to DKK 8,911,520. The solvency ratio was 55.8%.

Gross Profit
DKK 8,494,392
Profit/Loss
DKK 2,665,035
Equity
DKK 8,911,520
Total Assets
DKK 15,980,690
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-8.5M2.7M8.9M0
2023-5.9M-463K6.2M0
2022-17.3M-3.3M6.7M0
2021-4.3M255K10M6
2020-6.8M2.6M9.7M6

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

STRAGEN NORDIC A/S wins public contractNov 1, 2024

STRAGEN NORDIC A/S has won the tender "Amgros 2025 2.1310.b" issued by Amgros I/S worth 129,999,998 DKK.

STRAGEN NORDIC A/S: The 2023 annual report is outJul 4, 2024

STRAGEN NORDIC A/S has published its annual report for 2023. Gross profit came to DKK 5,930,803, and the net result was DKK -462,986.

Ludovic Alonzi joins the board of STRAGEN NORDIC A/SApr 4, 2024

As of April 4, 2024, Ludovic Alonzi has joined the board of directors of STRAGEN NORDIC A/S.

Jean-Yves Paul Etienne Desmottes leaves the board of STRAGEN NORDIC A/SApr 4, 2024

As of April 4, 2024, Jean-Yves Paul Etienne Desmottes has left the board of directors of STRAGEN NORDIC A/S.

About STRAGEN NORDIC A/S

STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.

Source: annual report 2025, Danish Business Authority